Cargando…

IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma

Esophageal adenocarcinoma (EAC) patients commonly present with advanced stage disease and demonstrate resistance to therapy, with response rates below 40%. Understanding the molecular mechanisms of resistance is crucial for improvement of clinical outcomes. IGFBP2 is a member of the IGFBP family of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Myers, Amy L., Lin, Lin, Nancarrow, Derek J., Wang, Zhuwen, Ferrer-Torres, Daysha, Thomas, Dafydd G., Orringer, Mark B., Lin, Jules, Reddy, Rishindra M., Beer, David G., Chang, Andrew C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694874/ https://www.ncbi.nlm.nih.gov/pubmed/26317790

Ejemplares similares

Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma
por: Lin, Jules, et al.
Publicado: (2015)

Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas
por: Ferrer-Torres, Daysha, et al.
Publicado: (2016)

Immune determinants of Barrett’s progression to esophageal adenocarcinoma
por: Lagisetty, Kiran H., et al.
Publicado: (2021)

UBCH5 Family Members Differentially Impact Stabilization of Mutant p53 via RNF128 Iso1 During Barrett’s Progression to Esophageal Adenocarcinoma
por: Ray, Paramita, et al.
Publicado: (2021)

Characterizing isoform switching events in esophageal adenocarcinoma
por: Zhang, Yun, et al.
Publicado: (2022)

MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer
por: He, Yanli, et al.
Publicado: (2015)

(18)F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer
por: Heiden, Brendan T., et al.
Publicado: (2018)

Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy
por: Tang, Dongfang, et al.
Publicado: (2018)

Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board (part 1 of 2 part series)
por: Quint, Leslie E., et al.
Publicado: (2013)

Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board
por: Quint, Leslie E., et al.
Publicado: (2013)

Image directed lymph node sampling for lung cancer staging
por: Quint, Leslie E, et al.
Publicado: (2014)

Chaperones and Ubiquitin Ligases Balance Mutant p53 Protein Stability in Esophageal and Other Digestive Cancers
por: Martinho, May San, et al.
Publicado: (2020)

Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance
por: Carraro, Amedeo, et al.
Publicado: (2017)

Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer
por: Zhang, Jie, et al.
Publicado: (2017)

Paired Exome Analysis of Barrett’s Esophagus and Adenocarcinoma
por: Stachler, Matthew D., et al.
Publicado: (2015)

Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
por: Dulak, Austin M., et al.
Publicado: (2013)

A Novel Serum 4-microRNA Signature for Lung Cancer Detection
por: Nadal, Ernest, et al.
Publicado: (2015)

Analysis of IGFBP7 expression characteristics in pan-cancer and its clinical relevance to stomach adenocarcinoma
por: Xu, Hui-Wen, et al.
Publicado: (2023)

Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma
por: Smith, Eric, et al.
Publicado: (2008)

Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer
por: Feng, Shumei, et al.
Publicado: (2017)

LINC00857 knockdown inhibits cell proliferation and induces apoptosis via involving STAT3 and MET oncogenic proteins in esophageal adenocarcinoma
por: Su, Wenmei, et al.
Publicado: (2019)

IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling
por: Oliva, Claudia R., et al.
Publicado: (2018)

IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation
por: Smith, E, et al.
Publicado: (2014)

The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma
por: Huang, Xinyi, et al.
Publicado: (2019)

Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.
por: Rachwal, W. J., et al.
Publicado: (1995)

Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage
por: Zhou, Zhangjian, et al.
Publicado: (2019)

Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway
por: Han, S, et al.
Publicado: (2014)

Whole Genome Expression Array Profiling Highlights Differences in Mucosal Defense Genes in Barrett's Esophagus and Esophageal Adenocarcinoma
por: Nancarrow, Derek J., et al.
Publicado: (2011)

Multiple bioinformatics analysis identifies IGFBP1 as associated with the prognosis of stomach adenocarcinoma
por: Luo, Xiao-Ye, et al.
Publicado: (2023)

The low IGFBP-3 level is associated with esophageal cancer patients: a meta-analysis
por: Song, Guiqin, et al.
Publicado: (2016)

Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
por: Jin, Li, et al.
Publicado: (2020)

Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer
por: Wang, Lihui, et al.
Publicado: (2016)

Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model
por: Zhang, Zhuo, et al.
Publicado: (2014)

Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas
por: Soldes, O S, et al.
Publicado: (1999)

Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2016)

IGFBP3 Colocalizes with and Regulates Hypocretin (Orexin)
por: Honda, Makoto, et al.
Publicado: (2009)

Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3
por: Zhao, Lei, et al.
Publicado: (2012)

Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma
por: Torng, Pao-Ling, et al.
Publicado: (2009)

Increased Concentrations of Insulin-Like Growth Factor Binding Protein (IGFBP)-2, IGFBP-3, and IGFBP-4 Are Associated With Fetal Mortality in Pregnant Cows
por: Mense, Kirsten, et al.
Publicado: (2018)

Phenotypic Characterization of Transgenic Mice Expressing Human IGFBP-5
por: Nguyen, Xinh-Xinh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kq8g5fg0l8ffsee9ud55a6bssl